WilliamJElliottMD

PubMed

• Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation.
  Elliott, W. J.,Bistrika, E. A.> ;Expert Opin Drug Saf. 2017 Oct 27
• Loop diuretics are most appropriate for hypertension treatment in chronic kidney disease.
  Elliott, W. J.,Jurca, S.> ;J Am Soc Hypertens. 1900 Jan 01
• Efficacy and safety of perindopril arginine + amlodipine in hypertension.
  Elliott, W. J.,Whitmore, J.,Feldstein, J. D.,Bakris, G. L.> ;J Am Soc Hypertens. 2015 Mar 26
• Therapy: Atenolol versus metoprolol tartrate-conflicting outcomes data.
  Randhawa, S. K.,Elliott, W. J.> ;Nat Rev Nephrol. 2014 Sep 10
• Rationale for establishing a mechanism to increase reimbursement to hypertension specialists.
  Elliott, W. J.,Egan, B.,Giles, T. D.,Bakris, G. L.,White, W. B.,Sansone, T. M.> ;J Clin Hypertens (Greenwich). 2013 Jun 05
• Generic Drugs for Hypertension: Are They Really Equivalent?
  Cooper-Dehoff, R. M.,Elliott, W. J.> ;Curr. Hypertens. Rep.. 2013 Aug
• Should ? Blockers No Longer Be Considered First-line Therapy for the Treatment of Essential Hypertension Without Comorbidities?
  Elliott, W.J., Childers, W.K.> ;Curr Cardiol Rep. 2011 Dec
• Calcium channel blockers.
  Elliott, W.J., Ram, C.S.> ;J Clin Hypertens (Greenwich). 2011 Sep
• What should be the blood pressure target for diabetic patients?
  Elliott, W.J.> ;Curr Opin Cardiol. 2011 Jul
• High prevalence of white-coat hypertension in spanish resistant hypertensive patients.
  Elliott, W.J.> ;Hypertension. 2011 May
• Network meta-analysis of heart failure prevention by antihypertensive drugs.
  Elliott, W.J., Basu, S., Meyer, P.M.> ;Arch Intern Med. 2011 Mar 14
• Do the blood pressure effects of nonsteroidal antiinflammatory drugs influence cardiovascular morbidity and mortality?
  Elliott, W.J.> ;Curr Hypertens Rep. 2010 Aug
• Hypertension.
  Elliott, W.J.> ;Curr Opin Cardiol. 2010 Jul
• Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment.
  Maitland, M.L., Kasza, K.E., Karrison, T., Moshier, K., Sit, L., Black, H.R., Undevia, S.D., Stadler, W.M., Elliott, W.J., Ratain, M.J.> ;Clin Cancer Res. 2009-10-01
• Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy.
  Elliott, W.J.> ;J Clin Hypertens (Greenwich). 2009-07-01
• Using diuretics in practice--one opinion.
  Elliott, W.J., Grimm, R.H.> ;J Clin Hypertens (Greenwich). 2008-11-01
• Renovascular hypertension: an update.
  Elliott, W.J.> ;J Clin Hypertens (Greenwich). 2008 Jul
• What factors contribute to the inadequate control of elevated blood pressure?
  Elliott, W.J.> ;J Clin Hypertens (Greenwich). 2008 Jan
• Systemic hypertension.
  Elliott, W.J.> ;Curr Probl Cardiol. 2007 Apr
• Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies.
  Elliott, W.J., Plauschinat, C.A., Skrepnek, G.H., Gause, D.> ;J Am Board Fam Med. 2007-01-01
• Drug interactions and drugs that affect blood pressure.
  Elliott, W.J.> ;J Clin Hypertens (Greenwich). 2006 Oct
• Blood pressure reduction is not the only determinant of outcome.
  Sever, P.S., Poulter, N.R., Elliott, W.J., Jonsson, M.C., Black, H.R., Sever, P.S., Poulter, N.R., Elliott, W.J., Jonsson, M.C., Black, H.R.> ;Circulation. 2006 Jun 13
• Clinical features in the management of selected hypertensive emergencies.
  Elliott, W.J.> ;Prog Cardiovasc Dis. 2006-03-01
• Device-guided breathing to lower blood pressure: case report and clinical overview.
  Elliott, W.J., Izzo, J.L.> ;MedGenMed. 2006
• A drug dose model for predicting clinical outcomes in hypertensive coronary disease patients.
  Elliott, W.J., Hewkin, A.C., Kupfer, S., Cooper-DeHoff, R., Pepine, C.J.> ;J Clin Hypertens (Greenwich). 2005 Nov
• Join now to see all